Hurler Syndrome - modelling new therapies
This research was completed on 5 August 2004
|Project Leader||Dr J Grainger, MB ChB, MRCP|
|Location||Department of Haematology, Royal Manchester Children's Hospital.|
|Grant awarded||17 May 2002|
|Start date||4 November 2002|
|End date||5 August 2004|
We do not provide medical advice. If you would like more information about a condition or would like to talk to someone about your health, contact NHS Choices or speak to your GP. Please see our useful links page for some links to health information, organisations we are working with and other useful organisations. We hope you will find these useful. We are not responsible for the content of any of these sites.
Hurler syndrome is a single gene disorder causing the deficiency of an important protein found throughout the body. Affected children suffer mental deterioration, have problems with many of their internal organs and rarely live beyond 10 years of age. Bone marrow transplantation is the current therapy but is limited by the availability of donors and the frequent rejection of the transplanted cells. Through genetic manipulation of the patient’s own bone marrow stem cells, the protein deficiency can be corrected. Using particular stem cells which have the potential to develop into many different types of tissue, Dr Grainger will investigate improved therapy for Hurler syndrome.